Tag: side-effects

With pharmaceutical companies pushing antipsychotics for off-label use, dementia patients are being put at risk for devastating health consequences. Research suggests safer alternatives exist—but why aren’t they being prioritized?

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

New research finds the negative drug effects most commonly associated with initiating antidepressant discontinuation are anxiety, suicidal thoughts, vomiting, and rashes.

An analysis of the huge increase in drugs for children, the role of Big Pharma, and a look at the impact on families and communities.

Since many psych patients become forced consumers, their advocates have a duty to be educated and concerned with adverse reactions.

Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.

After suffering PTSD in the late 1980s, I reluctantly accepted antidepressants. In time, I had resolved the trauma, but when I tried to stop the antidepressants (Prozac, and later Zoloft), I assumed my desperate feelings and “return” of depression were an indication I had an imbalance and needed those drugs. I didn’t understand I was experiencing withdrawal. (I was never told that for most people, psychiatric medications need to be tapered.)

A new survey exploring antipsychotic user experience finds that more than half of the participants report only negative experiences.

A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.

A review of 73 antidepressant studies finds that 12% more people drop out of clinical trials when taking antidepressants than when taking placebo, evidence that many find the adverse effects of antidepressants difficult to tolerate.

The Hopkins psychiatrist glances up at me, then looks at my chart. “I remember the first time—and the second—when the depression lifted I felt like a party girl.” How long did that last? “A couple of days…three, maybe.” That’s a couple of days too long. You have all the signs of bipolar II.

Experts across the globe point to the harms of drug companies’ influence on research, practice, and education in healthcare noting that it compromises patient care.

A new special issue brings together articles exploring the harmful effects of simultaneous multiple medication use.

A new study found that taking an antidepressant medication was associated with a heightened risk of suicide using violent means.

A new study has found that antidepressants are ineffective for reducing suicide attempts. Researchers report that the risk of suicide is particularly high in the first month after starting an antidepressant.

Throughout the past two decades, studies have warned of increased suicide rates in those taking antidepressants, especially in children and adolescents. Researchers also documented...

People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.

Recent claims about antidepressant effectiveness have been based on misleading statements and misunderstandings of the science.

Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.

A new study finds that more than a third of Americans are taking prescription drugs that can cause depressive symptoms as a side-effect.

Researchers find that nearly half of cognitive behavioral therapy (CBT) patients experience treatment side effects.

Researchers take action after study exposes enduring sexual dysfunction as a potential side effect of serotonin reuptake inhibiting antidepressants, 5α-reductase inhibitors, and isotretinoin.

A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.

Dr. Madhukar Trivedi and colleagues find that the SSRI sertraline does not reduce depressive symptoms any more than placebo in people with Chronic Kidney Disease.